Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Advies: vergoed efgartigimod alfa (Vyvgart) voor behandeling myasthenia gravis
jun 2024 | Neuro-musculair